Clinical Trials · NCT00886626
GLP-1 Therapy for Weight Loss and Improved Glucose Tolerance in Obese Children
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- University of Minnesota
- Enrollment
- 12
- Start date
- May 2009
- Locations
- 1 site, United States
- Primary endpoint
- Change in Body Mass Index (BMI)